In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution | Zendy

Stephen Pham | Zendy; Gary T. Ferguson | Zendy; Edward Kerwin | Zendy; Thomas Goodin | Zendy; Alistair Wheeler | Zendy; Andrea Bauer | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vitro Characterization of the eFlow Closed System Nebulizer with Glycopyrrolate Inhalation Solution

Author(s) -

Stephen Pham,

Gary T. Ferguson,

Edward Kerwin,

Thomas Goodin,

Alistair Wheeler,

Andrea Bauer

Publication year - 2017

Publication title -

journal of aerosol medicine and pulmonary drug delivery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.678

H-Index - 68

eISSN - 1941-2703

pISSN - 1941-2711

DOI - 10.1089/jamp.2017.1384

Subject(s) - nebulizer , glycopyrrolate , inhalation , anesthesia , medicine , chemistry , atropine

Glycopyrrolate administered by a novel, investigational eFlow ® Closed System (CS) nebulizer (eFlow CS) is being evaluated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). The eFlow CS is a hand-held, vibrating membrane nebulizer optimized to deliver 1 mL of glycopyrrolate solution into the lung in <3 minutes. Clinical studies have shown improvements in lung function of subjects treated with nebulized glycopyrrolate.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research